6,967
Views
3
CrossRef citations to date
0
Altmetric
Research

Caffeine versus aminophylline for the prevention of apnoea of prematurity in a teaching hospital in South Africa

, &
Pages 140-145 | Received 26 Jun 2014, Accepted 26 Oct 2014, Published online: 27 Feb 2015

References

  • Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354:2112–21.10.1056/NEJMoa054065
  • Wong DL, editor. Whaley and Wong’s nursing care of infants and children. 5th ed. Louis: Mosby-Year Book; 1995. p. 1344, 1359.
  • Kriter KE, Blanchard J. Management of apnoea in infants. Clin Pharm. 1989;8:577–87.
  • Zenk KE, Sills JH, Koeppel RM. Neonatal medications and nutrition: a comprehensive guide. 3rd ed. Santa Rosa: NICU Ink Book; 2003.
  • Comer AM, Perry CM, Figgitt DP. Caffeine citrate. Paediatr Drugs. 2001;3:61–79.10.2165/00128072-200103010-00005
  • Statistical Document of the Department of Paediatrics (NICU). Dr George Mukhari Hospital; 2007.
  • Brenner GM. Pharmacology. 3rd ed. Philadelphia, PA: W.B. Saunders; 2000. p. 294.
  • Behrman RE, Kliegman RM, editor. Nelson essentials of pediatrics. 3rd ed. Philadelphia, PA: WB Saunders; 1998. p. 463.
  • Bhatia J. Current options in the management of apnea of prematurity. Clin Pediatr (Phila). 2000;39:327–36.10.1177/000992280003900602
  • Henderson-Smart DJ, Steer PA. Caffeine versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev 1998;(2) Art. No.: CD00027. doi: 10.1002/14651858.CD000273
  • Erenberg A, Leff RD, Haack DG, et al. Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study. Pharmacotherapy. 2000;20:644–52.10.1592/phco.20.7.644.35167
  • Scanlon JEM, Chin KC, Morgan MEI, et al. Caffeine or theophylline for neonatal apnoea? Arch Dis Child. 1992;67:425–8.10.1136/adc.67.4_Spec_No.425
  • Mueni E, Opiyo N, English M. Caffeine for the management of apnea in preterm infants. Int Health. 2009;1:190–5.10.1016/j.inhe.2009.09.005
  • Schmidt B, Ohlsson A, Davis P. Caffeine therapy for apnoea of prematurity in very low-birthweight infants. Hamdan Med J. 2012 [cited 2014 Oct 08]. doi: 10.7707/hmj.v5i3.190. Available from http://hamdanjournal.org/journal/index.php?journal=HAMDAN&page=article&op=view&path%5B%5D=190&path%5B%5D=301.
  • Schmidt B, Anderson P, Doyle L, et al. The caffeine for apnea of prematurity (CAP) trial: preliminary outcomes at 5 years. Pediatr Res. 2011;70:24–24. doi: 10.1038/pr.2011.249.10.1038/pr.2011.249
  • Schmidt B, Anderson PJ, Doyle LW, et al. Caffeine for Apnea of Prematurity (CAP) Trial Investigators. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA 2012;307(3):275–82. doi: 10.1001/jama.2011.2024.10.1001/jama.2011.2024
  • Marcus CL, Meltzer LJ, Roberts RS, et al. Caffeine for apnea of prematurity–sleep study. Am J Respir Crit Care Med. 2014 Oct 1;190(7):791–9. doi: 10.1164/rccm.201406-1092OC.